Document 1yrxnarX5YL5xnb80znG5XYZq

CHEMICAL MANUFACTURERS ASSOCIATION October 24,1995 Dear Vinyl Chloride Health Committee Members: The following items are enclosed: 1. agenda for our October 31,1995 meeting; 2. Questions for Consideration With Respect to the Proposed University of Louisville Brain Cancer/VCM Case-Control Study. Jonathan Ramlow, Ed Beeler and I plan to meet with Carlo Tamburo in the next several weeks. Please review the list and bring to the meeting any additional questions that you may want to ask of Carlo Tamburo; 3. comments on "Protocol for CMA Vinyl Chloride Mortality Study." Jonathan Ramlow prepared these comments on the AEI protocol based on both Mark Gruenwald's and his own review of the AEI protocol. The comments have been submitted to Ken Mundt of AEI. I have invited Ken Mundt to attend our Committee meeting on October 31,1995; 4. letter to ATSDR on Vinyl Chloride Protocol, for Combined Inhalation Two-Generation Reproduction and Developmental Toxicity Study in CD Rats. Bill Breslin of Dow Chemical responded to the ATSDR Peer Reviewers' comments and revised the first draft protocol; and, 5. Memorandum of Understanding for Voluntary Research Program Under Section 104 (I) (5) of CERCLA between ATSDR and Halogenated Solvents Industry Alliance, Inc. Please review this MOU prior to the meeting and bring your comments, as ATSDR may propose a similar MOU for the Vinyl Chloride Health Effects research program. Please call me at (202) 887-1192 if you have any questions. I am looking forward to seeing you at our October 31 meeting. Sincerely, -, Hasmukh Shah Manager, Vinyl Chloride Panel Enclosures 2301 M St-eet, NVV, Washington, DC 20037 Telephone 2G2-Q37-r00 Fax 202-887-1237 ^ BFG 00102 LyJ Responsible Care H A Public Commitment